Fractyl Health (GUTS) Profit After Tax (2023 - 2026)
Fractyl Health (GUTS) reported Profit After Tax of $9.2 million for Q1 2026, up 138.84% year-on-year from $3.9 million in Q1 2025, and up 121.08% quarter-over-quarter from -$43.7 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Profit After Tax data on file, last reported at $9.2 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 138.84% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at -$108.0 million (down 21.2% YoY), and the FY2025 full-year result was -$141.0 million, down 105.19% from the prior year.
- Profit After Tax for Q1 2026 stood at $9.2 million, up from -$43.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $9.2 million in Q1 2026 and bottomed at -$45.6 million in Q3 2025.
- A 4-year average of -$21.3 million and a median of -$23.2 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 614.48% in 2025 and jumped 138.84% in 2026, its largest moves.
- Tracing GUTS's Profit After Tax over 4 years: stood at -$19.2 million in 2023, then slumped by 30.19% to -$25.0 million in 2024, then sank by 75.12% to -$43.7 million in 2025, then surged by 121.08% to $9.2 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $9.2 million, -$43.7 million, and -$45.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.22 Mn |
| Dec 31, 2025 | -43.73 Mn |
| Sep 30, 2025 | -45.60 Mn |
| Jun 30, 2025 | -27.89 Mn |
| Mar 31, 2025 | -23.74 Mn |
| Dec 31, 2024 | -24.97 Mn |
| Sep 30, 2024 | -23.17 Mn |
| Jun 30, 2024 | -17.23 Mn |
| Mar 31, 2024 | -3.32 Mn |
| Dec 31, 2023 | -19.18 Mn |
| Sep 30, 2023 | -15.75 Mn |
| Jun 30, 2023 | -30.23 Mn |
| Mar 31, 2023 | -11.93 Mn |